{
    "id": 21780,
    "cites": 42,
    "cited_by": 0,
    "reference": [
        "Iuga AO, McGuire MJ: Adherence and health care costs. Risk Management and Healthcare Policy 2014;7:3544",
        "Jha AK, Aubert RE, Yao J, Teagarden JR, Epstein RS: Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Affairs 2012;31:1836-1846",
        "Lee WC, Balu S, Cobden D, Joshi A, Pashos C: Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Managed Care Interface 2006;19:31-41",
        "Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA: Medication adherence leads to lower health care use and costs despite increased drug spending. Health Affairs 2011;30:91-99",
        "Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS: Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost. Medical Care 2005;43:521-530",
        "McNabb WL: Adherence in diabetes: Can we define it and can we measure it? Diabetes Care 1997;20:215218",
        "Hansen RA, Farley JF, Droege M, Maciejewski ML: A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Clin Therapeutics 2010;32:1308-1319",
        "Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD: Comparison of Methods to Assess Medication Adherence and Classify Nonadherence. Annals of Pharmacotherapy 2009;43:413-422",
        "Package leaflet metformin [article online], Available from https://www.medicines.org.uk/emc/PIL.24850.latest.pdf. Accessed 01.10.2015",
        "Paes AHP, Bakker A, Soe-Agnie CJ: Impact of Dosage Frequency on Patient Compliance. Diabetes Care 1997;20:1512-1517",
        "Hess LM, Raebel MA, Conner DA, Malone DC: Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures. Annals of Pharmacotherapy 2006;40:1280-1288",
        "Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC: Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Current Medical Research and Opinion 2009;25:2303-2310",
        "Kozma CM, Dickson M, Phillips AL, Meletiche DM: Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient preference and adherence 2013;7:509-516",
        "Krueger KP, Berger BA, Felkey B: Medication adherence and persistence: a comprehensive review. Advances in Therapy 2005;22:313-356",
        "Nichol MB, Wu J, Knight TK, Liberman JN: Medication Non-Adherence and Non-Persistence in a Managed Care Diabetes Mellitus Population. Value in Health 2009;12:A103-A103",
        "Ho P, Rumsfeld JS, Masoudi FA, et al.: Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine 2006;166:1836-1841",
        "Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA: A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;",
        "Diabetes Programme [article online], 2015. Available from http://www.who.int/diabetes/en/. Accessed",
        "De Sonnaville J, Heine R: Non-insulin dependent diabetes mellitus: presentation and treatment. MEDICINE 1997;25:23-26",
        "Bergman U: Utilization of antidiabetic drugs in the island of gotland, sweden: Agreement between wholesale figures and prescription data. European Journal of Clinical Pharmacology 1978;14:213-220",
        "Kildemoes WH, S\u00c3\u0083\u00c2\u00b8rensen TH, Hallas J: The Danish National Prescription Registry. Scandinavian Journal of Public Health 2011;39:38-41",
        "Carstensen B, Kristensen JK, Marcussen MM, Borch-Johnsen K: The National Diabetes Register. Scandinavian Journal of Public Health 2011;39:58-61",
        "Jensen VM, Rasmussen AW: Danish education registers. Scandinavian Journal of Public Health 2011;39:9194",
        "Lynge E, Sandegaard JL, Rebolj M: The Danish National Patient Register. Scandinavian Journal of Public Health 2011;39:30-33",
        "Sorts\u00c3\u0083\u00c2\u00b8 C, Thygesen LC, Br\u00c3\u0083\u00c2\u00b8nnum-Hansen H: Database on Danish population-based registers for public health and welfare research. Scandinavian Journal of Public Health 2011;39:17-19",
        "World Health Organization Collaborating Centre for Drug Statistics Methodology W: ATC Index with DDDs. Oslo, 2009",
        "Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: Methods, validity, and applications. Journal of clinical epidemiology 1997;50:105-116",
        "Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H, Sjoqvist F: Drug utilization 90%--a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998;54:113-118",
        "Frey S, Stargardt T: Performance of compliance and persistence measures in predicting clinical and economic outcomes using administrative data from German sickness funds. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2012;32:880-889",
        "Geisel-Marbaise S, Stummer H: Theoretische und reale adherence bei Diabetikern. Heilberufe 2009;61:104111",
        "Grimmsmann T, Himmel W: Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes? European Journal of Clinical Pharmacology 2011;67:847-854",
        "PHARMAC SMPM: Statin usage in Australia and New Zealand, and problems with use of DDDs. BMJ 2004;328",
        "Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, Gilbert AL: Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Research and Clinical Practice 2010;87:385-393",
        "Chini F, Pezzotti P, Orzella L, Borgia P, Guasticchi G: Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sources. BMC Public Health 2011;11:688",
        "Kuo RN, Dong Y-H, Liu J-P, Chang C-H, Shau W-Y, Lai M-S: Predicting healthcare utilization using a pharmacy-based metric with the WHO\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s anatomic therapeutic chemical algorithm. Medical Care 2011;49:1031-1039",
        "Lichtenberg FR: The impact of cardiovascular drug innovation on the longevity of elderly residents of Switzerland, 2003-2012. Nordic Journal of Health Economics 2015;",
        "Krousel-Wood M, Thomas S, Muntner P, Morisky D: Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Current opinion in cardiology 2004;19:357-362",
        "Heidenreich PA: Patient adherence: the next frontier in quality improvement. The American journal of medicine 2004;117:130-132",
        "Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, Aubert RE: Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care 2015;38:604-609",
        "Koulayev S, Skipper N, Simeonova E: Who is in control? The determinants of patient adherence with medication therapy. In NBER Working Paper 19496, National Bureau of Economic Research, 2013",
        "Cost-effectiveness thresholds [article online], Available from http://www.who.int/choice/costs/CER_thresholds/en/. Accessed 01.10.2015",
        "O'Shea M, Teeling M, Bennett K: The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: A retrospective cross-sectional study using a national pharmacy claims database. BMC Health Services Research 2013;13:23"
    ]
}